Touyun Biotech Group Limited
HKEX:1332.HK
0.154 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2012 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 74.267 | 95.273 | 103.367 | 149.535 | 166.29 | 146.747 | 136.758 | 115.426 | 91.36 | 161.048 | 181.648 | 189.463 | 159.307 | 219.038 | 98.661 | 0 | -101.521 | 159.583 | 126.384 | 205.692 | 191.348 | 222.203 | 214.199 | 0 | 0 |
| Cost of Revenue
| 41.959 | 73.599 | 68.437 | 87.981 | 107.725 | 91.671 | 84.78 | 61.584 | 60.588 | 105.79 | 111.412 | 139.414 | 114.676 | 159.479 | 120.446 | 0 | 101.911 | 135.206 | 145.516 | 170.135 | 160.651 | 186.791 | 180.139 | 0 | 0 |
| Gross Profit
| 32.308 | 21.674 | 34.93 | 61.554 | 58.565 | 55.076 | 51.978 | 53.842 | 30.772 | 55.258 | 70.236 | 50.049 | 44.631 | 59.559 | -21.785 | 0 | -203.432 | 24.377 | -19.132 | 35.557 | 30.697 | 35.412 | 34.06 | 0 | 0 |
| Gross Profit Ratio
| 0.435 | 0.227 | 0.338 | 0.412 | 0.352 | 0.375 | 0.38 | 0.466 | 0.337 | 0.343 | 0.387 | 0.264 | 0.28 | 0.272 | -0.221 | 0 | 2.004 | 0.153 | -0.151 | 0.173 | 0.16 | 0.159 | 0.159 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 22.293 | 0 | 21.203 | 0 | 23.336 | 0 | 27.918 | 0 | 26.124 | 0 | 40.766 | 0 | 29.188 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 58.393 | 58.468 | 59.539 | 63.254 | 64.995 | 63.783 | 62.298 | 66.084 | 55.46 | 55.924 | 79.586 | 98.918 | 108.79 | 138.23 | 61.354 | 0 | 22.539 | 75.144 | 18.634 | 20.481 | 18.808 | 19.969 | 17.111 | 0 | 0 |
| Selling & Marketing Expenses
| 8.579 | 12.301 | 11.406 | 16.148 | 10.283 | 10.084 | 8.576 | 9.874 | 7.786 | 11.681 | 11.331 | 16.644 | 15.001 | 17.242 | 16.928 | 0 | 5.766 | 6.909 | 6.559 | 8.014 | 7.128 | 8.962 | 7.087 | 0 | 0 |
| SG&A
| 68.668 | 76.165 | 70.758 | 86.994 | 75.59 | 67.7 | 70.531 | 80.857 | 64.892 | 69.506 | 92.226 | 117.578 | 123.791 | 94.118 | 78.282 | 0 | 28.305 | 82.053 | 25.193 | 28.495 | 25.936 | 28.931 | 24.198 | 0 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 68.668 | 76.165 | 70.758 | 86.994 | 75.59 | 67.7 | 70.531 | 80.857 | 64.892 | 69.506 | 92.226 | 207.449 | 108.885 | 257.428 | 77.065 | 0 | 63.033 | 109.641 | 360.975 | 26.811 | 26.437 | 25.942 | 23.919 | 0 | 0 |
| Operating Income
| -36.36 | -54.491 | -35.828 | -25.44 | -17.025 | -12.624 | -18.553 | -27.015 | -34.12 | -14.248 | -21.99 | -67.529 | -79.16 | -34.559 | -100.067 | 0 | -231.737 | -54.391 | -47.61 | 7.704 | 4.057 | 6.839 | 9.862 | 0 | 0 |
| Operating Income Ratio
| -0.49 | -0.572 | -0.347 | -0.17 | -0.102 | -0.086 | -0.136 | -0.234 | -0.373 | -0.088 | -0.121 | -0.356 | -0.497 | -0.158 | -1.014 | 0 | 2.283 | -0.341 | -0.377 | 0.037 | 0.021 | 0.031 | 0.046 | 0 | 0 |
| Total Other Income Expenses Net
| -12.785 | -110.886 | -49.253 | -87.435 | -69.283 | -8.163 | -53.321 | -40.617 | -24.128 | -128.727 | -45.682 | -101.394 | -3.891 | -86.325 | 1.152 | 0 | -32.302 | -27.977 | 386.241 | 1.781 | -0.448 | 3.021 | 0.348 | 0 | 0 |
| Income Before Tax
| -49.145 | -187.504 | -85.081 | -112.875 | -86.308 | -51.096 | -71.874 | -89.277 | -58.248 | -142.975 | -67.672 | -168.923 | -83.051 | -150.072 | -98.915 | 0 | -270.719 | -85.653 | 341.916 | 8.843 | 4.313 | 9.502 | 10.21 | 0 | 0 |
| Income Before Tax Ratio
| -0.662 | -1.968 | -0.823 | -0.755 | -0.519 | -0.348 | -0.526 | -0.773 | -0.638 | -0.888 | -0.373 | -0.892 | -0.521 | -0.685 | -1.003 | 0 | 2.667 | -0.537 | 2.705 | 0.043 | 0.023 | 0.043 | 0.048 | 0 | 0 |
| Income Tax Expense
| -0.326 | -0.038 | 0.022 | 1.523 | 1.95 | 0.771 | 0.2 | -2.722 | 0.006 | 3.008 | 1.205 | 1.94 | 0.049 | 3.392 | 0.837 | 0 | 0.037 | 0.462 | 0.598 | 0.962 | 0.804 | 1.219 | 1.561 | 0 | 0 |
| Net Income
| -47.969 | -184.988 | -83.951 | -109.999 | -88.066 | -11.576 | -61.372 | -86.555 | -82.221 | -129.558 | -70.955 | -171.039 | -82.838 | -152.74 | -92.486 | 0 | -270.756 | -86.115 | 341.374 | 8.092 | 2.257 | 7.291 | 6.144 | 0 | 0 |
| Net Income Ratio
| -0.646 | -1.942 | -0.812 | -0.736 | -0.53 | -0.079 | -0.449 | -0.75 | -0.9 | -0.804 | -0.391 | -0.903 | -0.52 | -0.697 | -0.937 | 0 | 2.667 | -0.54 | 2.701 | 0.039 | 0.012 | 0.033 | 0.029 | 0 | 0 |
| EPS
| -0.017 | -0.066 | -0.03 | -0.039 | -0.031 | -0.004 | -0.022 | -0.031 | -0.032 | -0.053 | -0.029 | -0.07 | -0.034 | -0.062 | -0.038 | 0 | -0.22 | -0.093 | 0.38 | 0.009 | 0.003 | 0.008 | 0.007 | 0 | 0 |
| EPS Diluted
| -0.017 | -0.066 | -0.03 | -0.039 | -0.031 | -0.004 | -0.022 | -0.031 | -0.032 | -0.053 | -0.029 | -0.07 | -0.034 | -0.062 | -0.038 | 0 | -0.22 | -0.093 | 0.38 | 0.009 | 0.003 | 0.008 | 0.007 | 0 | 0 |
| EBITDA
| -27.559 | -158.529 | -70.039 | -91.918 | -52.475 | -28.748 | -54.379 | -59.899 | -27.325 | -115.54 | -37.537 | -131.227 | -66.189 | -28.217 | -97.024 | 0 | -231.008 | -53.264 | -45.932 | 9.976 | 6.631 | 9.462 | 0 | 0 | 0 |
| EBITDA Ratio
| -0.371 | -0.302 | -0.241 | -0.037 | -0.023 | 0.009 | -0.071 | -0.112 | -0.216 | -0.01 | -0.017 | -0.314 | -0.415 | -0.129 | -0.983 | 0 | 2.275 | -0.334 | -0.363 | 0.048 | 0.035 | 0.043 | 0.058 | 0 | 0 |